Skip to main content

CGT Catapult: Past and present experience of ATMP in the UK to inform future best practice

The Cell and Gene Therapy Catapult (CGT Catapult) is an independent not-for-profit innovation and technology organisation committed to the advancement of cell and gene therapies. 

This round table report published by CGT Catapult summarises discussions between industry, NHS, regulators and patient groups on the past, present and future challenges in the UK ATMP ecosystem.

A press release is available here.

cgt catapult

CGT Catapult's roundtable summary: How can we use past & current experience to inform future best practice and ensure system readiness for routine ATMP clinical adoption? 

Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts